Cancer Medicines Forum workshop
April 5, 2024
Amsterdam, NL (Hybrid Event)
The European Medicines Agency (EMA) and EORTC are co-chairing the Cancer Medicines Forum (CMF), whose goal is to support policy decisions to facilitate treatment optimisation in Europe with a focus on post-licensing questions based on clinically relevant end-points for patients in the healthcare setting.
The CMF will report its observations and preliminary solutions to address treatment optimisation at a hybrid workshop at the EMA under the Auspices of the EU Belgian Presidency.
Date: Friday, 5 April 2024, 1:00-6:00 PM (CEST)
Location: European Medicines Agency, Amsterdam
Registration will close on 1 March 2024 for in-person participation and will remain open until 29 March 2024 for online participation.
Next events
EORTC Brain Tumour Group Spring Meeting
February 21
EORTC HQ, Brussels, Belgium
EORTC Melanoma Group Spring Meeting 2025
March 20 - March 21
Frankfurt, Germany
EORTC Lymphoma Group Spring Meeting 2025
March 21
Copenhagen, Denmark
ECHNO 2025
March 26 - March 29
Amsterdam, Netherlands
EORTC Quality of Life Group Spring Meeting 2025
March 27 - March 28
Rotterdam, Netherlands